Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Khazragy N. | |
dc.contributor.author | Ghozy S. | |
dc.contributor.author | Matbouly S. | |
dc.contributor.author | Zaki W. | |
dc.contributor.author | Safwat G. | |
dc.contributor.author | Hussien G. | |
dc.contributor.author | Khalifa O. | |
dc.contributor.other | Clinical Pathology and Haematology Department | |
dc.contributor.other | Faculty of Medicine | |
dc.contributor.other | Ain Shams University Biomedical Research Department | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Neurosurgery Department | |
dc.contributor.other | Faculty of Medicine | |
dc.contributor.other | Mansoura University | |
dc.contributor.other | Mansoura | |
dc.contributor.other | Egypt; Department of Paediatric | |
dc.contributor.other | Faculty of Medicine | |
dc.contributor.other | Ain Shams University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Biochemistry | |
dc.contributor.other | Faculty of Medicine | |
dc.contributor.other | Ain Shams University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Department of Molecular Biology | |
dc.contributor.other | Faculty of Biotechnology | |
dc.contributor.other | October University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:40:34Z | |
dc.date.available | 2020-01-09T20:40:34Z | |
dc.date.issued | 2019 | |
dc.description | Scopus | |
dc.description.abstract | Objectives: To investigate the correlation of homeobox (HOX) transcript antisense RNA expression with clinicopathological features and the clinical prognosis of the patients with chromosome 12p abnormalities associated acute myeloid leukemia (AML). We also investigate the association of 12p chromosomal on the expression of HOTAIR, miRNA-193a, and c-kit gene as targeting genes for HOTAIR in AML. Methods: AML patients with 12p chromosomal abnormalities were recruited and compared to AML with other chromosomal abnormalities rather than 12p. The long noncoding RNA (lncRNA) �HOTAIR,� miR-193a, and c-Kit genes expression were measured in bone marrow samples using Syber green based real-time polymerase chain reaction. Results: We found a significant difference for the expression levels of HOTAIR, c-kit, and miR-193a between 12p abnormalities associated AML and those without. The survival analysis revealed that patient's with low expression levels of HOTAIR and c-kit had significantly better survival and leukemia free survival. In contrast, miR-193a was associated with better overall survival but not leukemia free survival. Conclusion: 12p abnormalities associated AML were associated with worse prognosis. Our results proved that HOTAIR, miR-193a, and c-kit genes are independent prognostic predictors in 12p chromosomal associated AML; therefore it may represent a novel therapeutic application in AML in the future. � 2019 Wiley Periodicals, Inc. | en_US |
dc.identifier.doi | https://doi.org/10.1002/jcb.28796 | |
dc.identifier.doi | PubMedID31038787 | |
dc.identifier.issn | 7302312 | |
dc.identifier.other | https://doi.org/10.1002/jcb.28796 | |
dc.identifier.other | PubMedID31038787 | |
dc.identifier.uri | https://t.ly/DXGyl | |
dc.language.iso | English | en_US |
dc.publisher | Wiley-Liss Inc. | en_US |
dc.relation.ispartofseries | Journal of Cellular Biochemistry | |
dc.relation.ispartofseries | 120 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | 12p aberrations | en_US |
dc.subject | 12p deletion | en_US |
dc.subject | acute myeloid leukemia | en_US |
dc.subject | c-KIT | en_US |
dc.subject | homeobox transcript antisense RNA | en_US |
dc.subject | miR-193a | en_US |
dc.subject | anthracycline | en_US |
dc.subject | asparaginase | en_US |
dc.subject | complementary DNA | en_US |
dc.subject | complementary RNA | en_US |
dc.subject | corticosteroid | en_US |
dc.subject | homeobox transcript antisense RNA | en_US |
dc.subject | long untranslated RNA | en_US |
dc.subject | microRNA | en_US |
dc.subject | microRNA 193a | en_US |
dc.subject | stem cell factor receptor | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | vincristine | en_US |
dc.subject | acute myeloid leukemia | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | Article | en_US |
dc.subject | bone marrow | en_US |
dc.subject | cancer prognosis | en_US |
dc.subject | cancer specific survival | en_US |
dc.subject | chromosome 12p | en_US |
dc.subject | chromosome aberration | en_US |
dc.subject | chromosome deletion | en_US |
dc.subject | controlled study | en_US |
dc.subject | female | en_US |
dc.subject | gene targeting | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | human tissue | en_US |
dc.subject | induction chemotherapy | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | minimal residual disease | en_US |
dc.subject | overall survival | en_US |
dc.subject | priority journal | en_US |
dc.subject | real time polymerase chain reaction | en_US |
dc.subject | survival analysis | en_US |
dc.title | Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Deschler, B., Acute myeloid leukemia: epidemiology and etiology (2006) Cancer, 107 (9), pp. 2099-2107; Heim, S., Mitelman, F., Cytogenetic analysis in the diagnosis of acute leukemia (1992) Cancer, 70, pp. 1701-1709; Grimwade, D., Walker, H., Harrison, G., The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML); analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial (2001) Blood, 98, pp. 1312-1320; Bilhou-Nabera, C., 12P abnormalities in myeloid malignancies (2011) Atlas Genet Cytogenet Oncol Haematol, 2, pp. 125-126; de Rooij, J., Beuling, E., Fornerod, M., Aberrations are a recurrent event in pediatric acute myeloid leukemia with poor clinical outcome (2014) Blood, 124, p. 1012; Crane, M.M., Strom, S.S., Halabi, S., Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia (1996) Cancer Epidemiol, Biomarkers Prev, 5, pp. 639-644; Chase, A., Reiter, A., Burci, L., Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12) (1999) Blood, 1999 (93), pp. 1025-1031; Hajjari, M., Salavaty, A., Review HOTAIR: an oncogenic long non-coding RNA in different cancers (2015) Cancer Biolo Med, 2015, pp. 1-9; Wang, J., Chen, D., He, X., Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition (2015) Cancer Cell Int, 15, p. 24; Han, L., Zhang, H.-C., Li, L., Li, C.-X., Di, X., Qu, X., Downregulation of long noncoding RNA HOTAIR and EZH2 induces apoptosis and inhibits proliferation, invasion, and migration of human breast cancer cells (2018) Cancer Biother Radiopharm, 2018 (33), pp. 241-251; Xing, C.-Y., Hu, X.-Q., Xie, F.-Y., Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia (2015) FEBS Lett, 2015 (589), pp. 1981-1987; Hao, S., Shao, Z., Original article HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis (2015) Int J Clin Exp Pathol, 8, pp. 7223-7228; Wu, S., Zheng, C., Chen, S., Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia (2015) Oncol Lett, 10, pp. 2410-2414; Sayad, A., Hajifathali, A., Hamidieh, A.A., Roshandel, E., Taheri, M., HOTAIR long noncoding RNA is not a biomarker for acute myeloid leukemia (AML) in Iranian patients (2017) Asian Pacific J Cancer Prev, 2017 (18), pp. 1581-1584; Mar�n, I.G.-G., Hern�ndez-S�nchez, M., Rodr�guez-Vicente, A.E., A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia (2016) Hematol Oncol, 34 (2), pp. 84-92; Translocations involving 12p in acute myeloid leukemia: association with prior myelodysplasia and exposure to mutagenic agents (1992) Genes, Chromosomes and Cancer, 5, pp. 252-254; Braulke, F., M�ller-Thomas, C., G�tze, K., Frequency of del (12p) is commonly underestimated in myelodysplastic syndromes: results from a German diagnostic study in comparison with an International Control Group (2015) Genes Chromosomes Cancer, 2015 (817), pp. 809-817; Eguchi, M., Eguchi-Ishimae, M., Tojo, A., Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) (1999) Blood, 93, pp. 1355-1363; Tosi, S., Harbott, J., Teigler-schlegel, A., t (7; 12)(q36; p13), a new recurrent translocation involving ETV6 in infant leukemia (2000) Genes, Chromosomes Cancer, 332, pp. 325-332; Boissel, N., Leroy, H., Brethon, B., Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) (2006) Leukemia, 20, pp. 965-970; Ayatollahi, H., Shajiei, A., Sadeghian, M.H., Prognostic importance of C-KIT mutations in core binding factor acute myeloid leukemia (2017) Hematol Oncol Stem Cell Ther, 10, pp. 1-7; Riera, L., Marmont, F., Toppino, D., Core binding factor acute myeloid leukaemia and c-KIT mutations (2013) Oncol Rep, 2013 (29), pp. 1859-1866; Garzon, R., Volinia, S., Papaioannou, D., Expression and prognostic impact of lncRNAs in acute myeloid leukemia (2014) Proc Natl Acad Sci USA, 111, pp. 18679-18684; Zhang, Y.-Y., Huang, S.-H., Zhou, H.-R., Chen, C.J.I.E., Role of HOTAIR in the diagnosis and prognosis of acute leukemia (2016) Oncol Rep, 36, pp. 3113-3122; D�az-Bey�, M., Brunet, S., Nomded�u, J., The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature (2015) Oncotarget, 6, pp. 31613-31627 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_256.png
- Size:
- 6.31 KB
- Format:
- Portable Network Graphics
- Description: